Three months in. You've been injecting every week, navigating nausea, celebrating small wins on the scale — and now you're wondering whether what you're seeing is normal, behind schedule, or ahead of the curve. You're not alone. "Wegovy results after 3 months" is one of the most searched questions among people who've just started semaglutide, and for good reason: the 3-month mark is when expectations and reality often collide.
This article breaks down exactly what the clinical trials show for the first 12 weeks, why results vary so much between individuals, and what you can do if your progress feels slower than you expected.
What Wegovy Results Look Like at 3 Months: The Clinical Picture
Wegovy (semaglutide 2.4 mg) was studied extensively in the STEP trial program. The headline number you've probably seen — 13.7% average body weight loss — comes from 68 weeks of treatment. But most people want to know what happens in the first 12–14 weeks, which is roughly the dose-escalation period.
Here's the important context: during the first three months, you are not yet at the full therapeutic dose. Wegovy's titration schedule looks like this:
- Weeks 1–4: 0.25 mg (starter dose — not a therapeutic dose)
- Weeks 5–8: 0.5 mg
- Weeks 9–12: 1.0 mg
- Weeks 13–16: 1.7 mg
- Week 17+: 2.4 mg (maintenance dose)
This means that at the true 3-month mark, most people are just finishing the 1.0 mg step — still well below the final dose. Weight loss during this ramp-up phase is real, but it's typically more modest than what comes later.
In STEP 1, participants had lost roughly 5–7% of their body weight by week 12. For someone starting at 220 lbs, that's approximately 11–15 pounds. Some people lose more, some less — but if you're in that range, you're tracking well with the clinical evidence.
Why Your 3-Month Results May Look Different From Someone Else's
Social media is full of dramatic before-and-after posts from people who claim to have lost 25 pounds in their first 3 months on Wegovy. While this does happen, it's not typical — and comparing yourself to those outliers can be genuinely discouraging.
Several factors influence how much weight you lose in the first 12 weeks:
Starting Weight
Weight loss on GLP-1s is typically expressed as a percentage of body weight. Someone starting at 280 lbs losing 6% drops about 17 pounds. Someone starting at 190 lbs losing 6% drops about 11 pounds. Both are excellent responses — they just look different on the scale.
Dose Tolerability
If you've had to pause or delay dose increases due to nausea, vomiting, or other GI side effects, your 3-month weight loss will naturally be lower. That's not a failure — that's your body adjusting. Slower titration is often recommended for people with significant side effects, and it doesn't predict worse long-term outcomes.
Dietary and Lifestyle Habits
Wegovy suppresses appetite powerfully, but it works best when paired with a higher-protein diet, adequate hydration, and consistent movement. People who continue eating primarily ultra-processed foods often see slower results, even with strong appetite suppression, because calorie density can still outpace hunger reduction.
Metabolic History
A history of multiple prior diets, insulin resistance, hypothyroidism, or certain medications can all slow the scale's response to semaglutide. If you're in any of these categories, your 3-month numbers may look modest even though the medication is working exactly as intended.
Important: Weight loss is not linear on Wegovy. Many people experience a noticeable stall in weeks 6–10 as their body adapts to the current dose, followed by renewed loss when the next dose step begins. A plateau at 3 months doesn't mean the medication has stopped working.
3 Months vs. 6 Months vs. 68 Weeks: The Full Trajectory
One of the most useful things to understand about Wegovy is that the majority of its weight-loss effect accumulates after the 3-month mark. Here's how the STEP 1 data breaks down across the full trial:
- Week 12 (~3 months): ~5–7% body weight lost
- Week 28 (~7 months): ~10–11% body weight lost
- Week 68 (~16 months): ~13.7% body weight lost (trial average)
Notice that more than half of the total weight loss in STEP 1 happened after the 3-month mark. If you're discouraged at month three, you may be judging a 16-month medication by its earliest chapter.
How Does Wegovy Compare to Tirzepatide at 3 Months?
If you're researching GLP-1 options or considering a switch, it's worth knowing that tirzepatide (Zepbound/Mounjaro) consistently outperforms semaglutide at every time point in head-to-head and individual trial data. In the SURMOUNT trials, tirzepatide users lost an average of 20.2% of body weight over the full trial period — and in the 2025 SURMOUNT-5 head-to-head study, tirzepatide showed 47% greater relative weight loss compared to semaglutide.
At the 3-month mark specifically, tirzepatide users tend to see slightly higher losses partly because tirzepatide's titration schedule reaches its lower therapeutic doses faster. However, both medications are doing meaningful work at 3 months — tirzepatide simply has a higher ceiling.
Want to see what your projected weight loss could look like on either medication? Use the free GLP-1 Weight Loss Calculator at GLP1Calc to get a personalized estimate based on your starting weight, medication, and timeline.
What Should You Actually Do at the 3-Month Mark?
Three months is a natural checkpoint. Here's how to make the most of it:
Review Your Numbers Honestly
Weigh yourself under consistent conditions (same time of day, same clothing) and calculate your percentage of body weight lost, not just the raw pounds. If you're at 5% or above, you're in line with clinical expectations. If you're below 3%, it's worth a conversation with your prescriber about whether your dose, diet, or underlying factors need attention.
Check Your Protein Intake
One underappreciated issue at 3 months: appetite suppression can become so effective that people aren't eating enough protein. This leads to muscle loss alongside fat loss, which slows metabolism and can stall the scale. Aim for at least 0.7–1.0 grams of protein per pound of goal body weight, even if your overall appetite is low.
Don't Abandon Ship Too Early
The most common mistake at 3 months is concluding the medication "isn't working" and stopping. Given that most of the drug's effect builds after month 3 as you reach maintenance dosing, stopping at this point means you never gave it a real chance. If you're seeing any weight loss and tolerating the medication, continuing is almost always the right call.
Talk to Your Prescriber About Dose Optimization
If you've been tolerating each dose well and aren't experiencing significant side effects, ask your provider whether you're on track with the titration schedule. Some people are kept at lower doses longer than necessary out of caution, even when they could safely progress.
The Bottom Line on Wegovy Results After 3 Months
A 5–7% weight loss at the 3-month mark is well-supported by clinical data and represents meaningful progress. It's not the dramatic transformation that gets shared on social media, but it's a strong biological signal that the medication is working — and that significantly more is coming as you reach and sustain maintenance dosing.
The people who see the best long-term results on Wegovy are almost always the ones who treat month 3 as the beginning of the story, not the final chapter.